Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LAP3 | P28838 | 3/20 | 1.00 |
| ▸ | FDPS | P14324 | 5/20 | 0.61 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.60 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.60 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.60 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.60 |
| ▸ | ANPEP | P15144 | 1/20 | 0.56 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.56 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7814294 | 1.00 | LAP3 (1.00) | LAP3FDPSS1PR2S1PR1S1PR3 | |
| SCHEMBL9307335 | 0.98 | LAP3 (1.00) | LAP3FDPSS1PR2S1PR1S1PR3 | |
| SCHEMBL1060233 | 0.98 | LAP3 (1.00) | LAP3FDPSS1PR2S1PR1S1PR3 | |
| SCHEMBL15876022 | 0.98 | LAP3 (1.00) | LAP3FDPSS1PR2S1PR1S1PR3 | |
| SCHEMBL745344 | 0.98 | LAP3 (1.00) | LAP3FDPSS1PR2S1PR1S1PR3 | |
| SCHEMBL5691911 | 0.98 | LAP3 (1.00) | LAP3FDPSS1PR2S1PR1S1PR3 | |
| SCHEMBL1059770 | 0.98 | LAP3 (1.00) | LAP3FDPSS1PR2S1PR1S1PR3 | |
| SCHEMBL5690430 | 0.98 | LAP3 (1.00) | LAP3FDPSS1PR2S1PR1S1PR3 | |
| SCHEMBL5691588 | 0.98 | LAP3 (1.00) | LAP3FDPSS1PR2S1PR1S1PR3 | |
| Bromide SCHEMBL6049728 | 0.96 | LAP3 (0.96) | LAP3FDPSS1PR2S1PR1S1PR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 229 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12251873-B2 | Three-dimensional printing | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2025-03-18 | — | — | US | claimed |
| EP-3765266-B1 | THREE-DIMENSIONAL PRINTING | HEWLETT PACKARD DEVELOPMENT CO (US) | 2024-02-21 | — | — | EP | claimed |
| CN-116438267-A | Polishing composition and method of use | 富士胶片电子材料美国有限公司 | 2023-07-14 | — | — | CN | claimed |
| US-20210213532-A1 | THREE-DIMENSIONAL PRINTING | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2021-07-15 | — | — | US | claimed |
| EP-3765266-A1 | THREE-DIMENSIONAL PRINTING | Hewlett-Packard Development Company, L.P. (US) | 2021-01-20 | — | — | EP | claimed |
| WO-2020072075-A1 | THREE-DIMENSIONAL PRINTING | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2020-04-09 | — | — | WO | claimed |
| US-12251873-B2 | Three-dimensional printing | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2025-03-18 | — | — | US | disclosed |
| EP-3765266-B1 | THREE-DIMENSIONAL PRINTING | HEWLETT PACKARD DEVELOPMENT CO (US) | 2024-02-21 | — | — | EP | disclosed |
| US-20240049494-A1 | MIXTURES AND USES THEREOF IN OPTOELECTRONIC FIELD | Zhejiang Brilliant Optoelectronic Technology Co.,Ltd. (CN) | 2024-02-08 | — | — | US | disclosed |
| CN-117242157-A | Mixture and application thereof in photoelectric field | 浙江光昊光电科技有限公司 | 2023-12-15 | — | — | CN | disclosed |
| WO-2022214031-A1 | MIXTURE AND USE THEREOF IN PHOTOELECTRIC FIELD | 浙江光昊光电科技有限公司 | 2022-10-13 | — | — | WO | disclosed |
| CN-108603104-B | Polythiourethane matrices comprising nanocrystals | 苏州润邦半导体材料科技有限公司 | 2021-10-26 | — | — | CN | disclosed |
| CN-108699432-B | Nanocrystal composites | 苏州润邦半导体材料科技有限公司 | 2021-10-26 | — | — | CN | disclosed |
| EP-1442027-A1 | SUBSTITUTED DIPHENYLOXAZOLES, THE SYNTHESIS THEREOF, AND THE USE THEREOF AS FLUORESCENCE PROBES | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2004-08-04 | — | — | EP | disclosed |
| WO-2004054923-A1 | TERNARY AND QUATERNARY NANOCRYSTALS, PROCESSES FOR THEIR PRODUCTION AND USES THEREOF | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2004-07-01 | — | — | WO | disclosed |
| US-20030105111-A1 | Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes | 3-DIMENSIONAL PHARMACEUTICALS, INC. | 2003-06-05 | — | — | US | disclosed |
| WO-2003031419-A1 | SUBSTITUTED DIPHENYLOXAZOLES, THE SYNTHESIS THEREOF, AND THE USE THEREOF AS FLUORESCENCE PROBES | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2003-04-17 | — | — | WO | disclosed |
| EP-1091958-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2001-04-18 | — | — | EP | disclosed |
| WO-2000001692-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2000-01-13 | — | — | WO | disclosed |
| US-5679842-A | Process for the preparation of aminomethanephosphonic acid and aminomethylphosphinic acids | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030105111-A1 | Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes | DHFR, FPR1, CYP1A1 | LAP3 1958/4885FDPS 96/4885S1PR2 3418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.